Geolin, Pepito B.

HRN: 25-58-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/17/2024
10/23/2024
IV
2.25G
Q6
Capmr
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines